Celltrion Investor Relations Material
Latest events
Investor Day 2024
Celltrion
Q1 2025
9 May, 2025
Q4 2024
16 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Celltrion Inc
Access all reports
Celltrion Inc. is a South Korea-based biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company focuses on monoclonal antibodies, biosimilars, and innovative biologic therapies for various medical conditions. Celltrion operates state-of-the-art biopharmaceutical production facilities and engages in global partnerships for the commercialization of its products. The company is headquartered in Incheon, South Korea, and its shares are listed on the KRX.
Key slides for Celltrion Inc
Investor Presentation
Celltrion Inc
Investor Presentation
Celltrion Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
A068270
Country
🇰🇷 South Korea